March is National Colorectal Cancer, Kidney Cancer, and Multiple Myeloma Cancer Awareness Month
|
|
-
UC San Diego has open recruitments for oncologists specializing in Breast cancer and Experimental Therapeutics MOASC News/ Career News
-
California Cancer Caucus’ Virtual Legislative Briefing on Cancer Prevention and Early Detection, Wednesday, March 9 California News
-
Tell CMS to Fix DIR Fees! Please submit comment on Proposed PBM Regulation by March 7th! National News
|
|
MOASC Programs - Save the Dates - All Times are Pacific
|
|
The Hoag Oncology Nursing Conference is virtual again this year. Word is, it is simply the best virtual oncology nursing event!
March 11-12, 2022 Hoag Oncology Nursing Conference
April 27 – May 1, 2022 Oncology Nursing Congress
|
|
March 26, 2022 - MOASC’s 7th Annual Oncology Summit & Research Symposium at the Hyatt Regency in Huntington Beach. This LIVE Meeting will follow a multi-tumor approach with nationally recognized speakers, which will review personalized cancer care and current clinical trials in Breast, Gastrointestinal, Genitourinary, Lung, CAR-T/Transplant and Myeloma. This will be a great opportunity to learn from experts and network with colleagues.
|
|
UC San Diego invites you to an interactive online learning experience on Gather-ed where you can earn free CME credits and learn about Advances in Basal Cell Carcinoma at your own pace from your own computer. We think you will find it enjoyable, and the time commitment is extremely modest and flexible.
|
|
You are cordially invited to a CME/CNE-certified, ABIM MOC-eligible, live webinar entitled, Personalized Approaches to HER2-Positive Breast Cancer Treatment, Thursday, April 21, 2022, 5:30 PM – 6:30 PM Pacific. This activity will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.
|
|
Career News
UC San Diego has the following open recruitments:
Sign up now to receive the MOASC Job Flash™! Please activate your new job alert.
|
|
MOASC Clinical Trial Database is on the MOASC website at www.moasc.org
|
|
As the COVID-19 pandemic has swept across California, many patients delayed critical
screening and diagnostic tests for detecting cancers. Due to delays, physicians are seeing more patients present with advanced stages of cancers that would have otherwise been
detected earlier with standard screening practices. Keeping up with medical care and cancer
screenings may contribute to the future health of Californians. MOASC, ANCO and the California Cancer Caucus invite you to a Virtual Legislative Briefing on Cancer Prevention and Early Detection, Wednesday, March 9, 2022, 10:00AM – 11:00AM-Pacific. Moderated by: Autumn J. Ogden-Smith, Director, California State Legislation, American Cancer Society – Cancer Action Network, Inc.; Senator Susan Rubio (D-Baldwin Park) – Invited;
The Impact of COVID on Cancer Care and the Path Forward presented by: Rana McKay, M.D., UC San Diego Moores Cancer Center; The Importance of Screening presented by: Margaret Hitchcock, PhD, California Colorectal Cancer Coalition (C4); How Delays in Screening Impact Patient Care presented by: Sukhmani Padda, M.D., Thoracic Medical Oncologist, Cedars-Sinai
The goal of the California Cancer Caucus (CCC) is to develop a continuous line of communication and education between stakeholders and health policy decision makers, as a resource for all cancer related public policy.
|
|
MOASC, the California Medical Association (CMA) and its local county medical societies have joined together with hundreds of organizations in opposing the so-called "Fairness for Injured Patients Act" (FIPA) because it will devastate our health care delivery system, hurt community health centers and raise health care costs for ALL Californians. FIPA will be on the ballot this November and, if passed, will effectively eliminate MICRA’s protections. Funded by a wealthy out-of-state trial attorney, this proposition would be a windfall for lawyers at the expense of California’s most vulnerable patients.
|
|
The CalHealthCares Loan Repayment Program application deadline has been extended to Friday, March 11, 2022. To help applicants with the process, CalHealthCares will be hosting a live Question and Answer webinar on Tuesday, March 1, from 12-1 p.m. to address applicant questions. CalHealthCares provides loan repayment on educational debt for California physicians and dentists who increase access to care to Medi-Cal patients. Eligible physicians can apply for a loan repayment award of up to $300,000 in exchange for a five-year service obligation. Eligible dentists can apply for a loan repayment award of up to $300,000 in exchange for a five-year service obligation or a Practice Support Grant of up to $300,000 in exchange for a 10-year service obligation. The program is funded by Proposition 56 voter-approved, tobacco tax revenues.
|
|
Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (A57329) - R3 - Effective February 24, 2022
This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
|
|
Billing and Coding: MolDX: FDA-Approved KRAS Tests (A54498) - R6 - Effective March 03, 2022. This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
|
|
Billing and Coding: MolDX: FDA-Approved EGFR Tests (A54422) - R4 - Effective March 03, 2022 . This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
|
|
March 10, 2022 Local and National Coverage Determinations (LCD/NCD) - After Hours
This webinar is intended for Medicare Part A and B Providers and will include: • Overview • National Coverage Determination (NCD) • Local Coverage Determination (LCD) • Medicare Coverage Database (MCD) • Resources.a
|
|
March 29, 2022 Medicare Secondary Payer (MSP) Part B Billing
This webinar is intended for Part B providers and will include: • Part B Billing Options, Payments and Calculations • Overpayment Process • Forms and Noridian Medicare Portal (NMP) • Avoiding Delays • Resources.
|
|
March 30, 2022 - Telehealth Provider Enrolling in Medicare
Learn telehealth regulations and how to enroll in Medicare as a provider or supplier. Learn about eligible providers, originating sites, distant site practitioners, and what type of equipment for communication is necessary for compliance.
|
|
CMS is replacing its Global and Professional Direct Contracting Model with a new accountable care organization model at year's end called the ACO Realizing Equity, Access, and Community Health Model. The new framework is intended to enhance care and health equity, and it will require ACOs to submit a plan outlining how they intend to reduce health care disparities and address the needs of underserved Medicare beneficiaries. Per CMS Deputy Administrator and Director of the CMS Innovation Center, “Under the ACO REACH Model, health care providers can receive more predictable revenue and use those dollars more flexibly to meet their patients’ needs — and to be more resilient in the face of health challenges like the current public health pandemic. The bottom line is that ACOs can improve health care quality and make people healthier, which can also lead to lower total costs of care.”
|
|
The Center for Medicare and Medicaid Innovation eliminated the accountable care organization transformation track from the Community Health and Rural Transformation Model, which offers upfront investments, outcomes-based payments and regulatory waivers to health care providers serving Medicare patients in rural areas. The CMS said qualified health care providers can still join the Medicare Shared Savings Program and the CHART program's community transformation track.
|
|
HHS sent $560 million in Provider Relief Fund money to more than 4,100 health care providers this week. The fourth phase of the program granted higher payments to smaller applicants and extra assistance to those that serve Medicaid, Medicare and Children's Health Insurance Program beneficiaries.
|
|
CMS announced a national coverage determination that expands coverage for lung cancer screening with low dose computed tomography (LDCT) to improve health outcomes for people with lung cancer. This final decision expands eligibility for people with Medicare to get lung cancer screening with LCDT by: 1) Lowering the starting age for screening from 55 to 50 years, 2) Reducing the tobacco smoking history from at least 30 packs per year to at least 20 packs per year.
|
|
Don’t Forget to Tell CMS to Fix DIR Fees! Please submit comment on Proposed PBM Regulation by March 7th! PBM abuses have been a hot topic in Washington for years. CMS is currently taking the first step in reining in these abuses by fixing the direct and indirect remuneration (DIR) fees that PBMs charge pharmacies. With the link to the one-stop page, you can share your perspective on DIR Fees with CMS and your members of Congress. With CMS finally showing a real interest in meaningful DIR fee regulation, the time is now to encourage follow-through and let lawmakers know this should only be the beginning of regulating PBM abuses!
|
|
The CDC significantly relaxed nationwide mask guidelines in accordance with new COVID-19 community-level metrics that account for new COVID-19 cases, hospital capacity and new hospitalizations. Under the new guidance, Americans residing in areas with low or medium community levels do not need to use masks in public or indoor settings, and the new metrics indicate only about 28% of Americans reside in areas where COVID-19 levels are high and masks should be used in schools and other indoor settings.
|
|
Affiliate Association News |
|
March 11-13, 2022, the 22nd Multidisciplinary Management of Cancers: A Case-based Approach returns to the Silverado Resort and Spa in Napa. The meeting is sponsored by the Association of Northern California Oncologists, Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and the UCSF Helen Diller Family Comprehensive Cancer Center. Registration is now open for HCP for in person and virtual attendance.
|
|
ASH has well-established mentorship programs and an outstanding record in supporting hematology professionals at every career stage. Applications for the 2022 Medical Educators Institute are open for submission through May 6. For the first time this year, ASH is offering application mentors for diverse and underrepresented groups in hematology, medical education, and the MEI program.
|
|
A new report, commissioned by COA and prepared by the pharmacy benefit manager (PBM) experts at Frier Levitt, LLC, offers one of the most comprehensive look in the abuses perpetuated by PBMs to date. |
|
Just Two Weeks Away. Will You Be There? The 2022 Community Oncology Conference is two days, but the agenda is packed with all the information you need to know to beat challenges in the coming year. At this year’s Conference, learn about the needs of community oncology practices in the future and how you can incorporate these lessons into your own practice. Learn to address socioeconomic, racial, and ethnic differences, which greatly affect how care is provided and outcomes. Hear how practices work to address these problems. On March 17-18, oncology professionals from around the country will gather at the Gaylord Palms Hotel in Kissimmee, Florida for the best oncology conference in the country.
|
|
CURE’s sister franchise, Physician’s Education Resource (PER) has an upcoming CME opportunity. As MOASC is a partner, PER is offering 35% discounted registration for MOASC physicians to the 39th Annual Miami Breast Cancer Conference, March 3-6, 2022 at the Fontainebleau Miami Beach, Miami Beach, FL. This event will be Live, In-person & Virtual
Program chairs: Patrick L. Borden, MD, Debu Tripathy, MD, Hope S. Rugo, MD, FASCO.
|
|
The Leukemia & Lymphoma Society News |
|
The Leukemia & Lymphoma Society presents Advances in Multiple Myeloma. This free telephone/web Educational Program is Wednesday, March 16, 2022, 11:00am-12:30pm Pacific.
Learn more about: current and latest advances in treatment; Determining treatment for your myeloma; Managing side effects; The importance of communicating with your treatment team.
|
|
MOASC is pleased to acknowledge and thank the following company for its generous support of your association. Please welcome and thank them when they call, e-mail and come to your office.
Incyte (Platinum Sponsor) is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Jakafi® (ruxolitinib); Pemazyre (pemigatinib); Monjuvi (tafasitamab-cxix).
|
|
This Thursday, March 3, 12:00pm Pacific, Janssen/Johnson & Johnson will introduce the Janssen Compass™ Patient Support Program. Presented by Brian Drennan, Associate Director, Patient & Caregiver Solutions, Janssen/Johnson & Johnson and Cortney Franz, NP, Oncology Clinical Educator, Janssen/Johnson & Johnson, Janssen Compass™ is a patient offering resource with a single point of contact for your patients, helping to clarify their path by providing information, education, and helping them become better advocates for themselves.
|
|
The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care. The material contained in the California Oncology Weekly is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the California Oncology Weekly may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in California Oncology Weekly should not be used as a substitute for such advice. This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein. CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.
|
|
|
|
|
|
|
